Medical Xpress November 26, 2024
James Taylor, PD Neurotechnology

The use of PD Neurotechnology’s pioneering telemonitoring device to assess Parkinson’s Disease (PD) symptoms and inform medication adjustments led to the majority of patients exhibiting improved or stable symptom manifestation, according to a study published in Frontiers in Neurology.

The study investigated the progression of PD symptoms over two years for 17 patients who were previously evaluated using traditional methods. Physicians integrated PDMonitor, PD Neurotechnology’s continuous device, for each patient and used it to assess symptoms in their daily lives. These assessments informed decisions about their care.

The results of the study provide real-world evidence that remote continuous monitoring with PDMonitor had a positive impact on PD symptom control:

  • The time patients in the study spent in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Provider, Survey / Study, Technology, Trends
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Telehealth gets short extension, physician pay is cut in spending bill
Sweat BioSensors: Emerging HealthTech market to watch in 2025
Amazon One Medical: the beginning of a text-based TeleHealth revolution?
Congress Extends Hospice Telehealth Flexibilities

Share This Article